Actions of N-arachidonyl-glycine in a rat inflammatory pain model

Molecular Pain

Volumn 3, Issue , 2007, Pages

  Succar, Rebecca ^a   Mitchell, Vanessa A ^a   Vaughan, Christopher W ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANALGESIC AGENT; CANNABINOID RECEPTOR AGONIST; DEXANABINOL; N ARACHIDONYL 4 AMINOBUTYRIC ACID; N ARACHIDONYLALANINE; N ARACHIDONYLGLYCINE; UNCLASSIFIED DRUG; ARACHIDONIC ACID DERIVATIVE; CANNABINOID RECEPTOR; DRUG DERIVATIVE; GLYCINE; N-ARACHIDONYLGLYCINE;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG POTENTIATION; HYPERALGESIA; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; ANIMAL; DISEASE MODEL; INFLAMMATION; INTRASPINAL DRUG ADMINISTRATION; REACTION TIME; SPRAGUE DAWLEY RAT;

ANIMALS; ARACHIDONIC ACIDS; DISEASE MODELS, ANIMAL; GLYCINE; INFLAMMATION; INJECTIONS, SPINAL; MALE; PAIN; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, CANNABINOID;

EID: 35648937451     PISSN: 17448069     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-8069-3-24     Document Type: Article

References (33)

1. Pertwee RG Pharmacological actions of cannabinoids Handbook of Experimental Pharmacology: Cannabinoids Berlin, Springer Pertwee RG 2005, 168:1-51.
2. Clayton N Marshall FH Bountra C O'Shaughnessy CT CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain Pain 2002, 96:253-260. 10.1016/S0304-3959(01)00454-7 11972997
3. Smith FL Fujimori K Lowe J Welch SP Characterization of D9-tetrahydrocannabinol and Anandamide Antinociception in Nonarthritic and Arthritic Rats Pharmacol Biochem Behav 1998, 60(1):183-191. 10.1016/ S0091-3057(97)00583-2 9610941
4. Kehl LJ Hamamoto DT Wacnik PW Croft DL Norsted BD Wilcox GL Simone DA A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain Pain 2003, 103(1-2):175-186. 10.1016/S0304-3959(02)00450-5 12749972
5. Hanus L Breuer A Tchilibon S Shiloah S Goldenberg D Horowitz M Pertwee RG Ross RA Mechoulam R Fride E HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor Proc Natl Acad Sci USA 1999, 96(25):14228-14233. 24419 10588688 10.1073/pnas.96.25.14228
6. De Vry J Denzer D Reissmueller E Eijckenboom M Heil M Meier H Mauler F 3- 2-cyano-3-(trifluoromethyl)phenoxy phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): A novel cannabinoid CB1/CB2 receptor partial agonist with antihyperalgesic and antiallodynic effects J Pharmacol Exp Ther 2004, 310(2):620-632. 10.1124/ jpet.103.062836 15140913
7. Herzberg U Eliav E Bennett GJ Kopin IJ The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain Neurosci Lett 1997, 221:157-160. 10.1016/ S0304-3940(96)13308-5 9121688
8. Compton DR Rice KC De Costa BR Razdan RK Melvin LS Johnson MR Martin BR Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities J Pharmacol Exp Ther 1993, 265(1):218-226. 8474008
9. Fox A Kesingland A Gentry C McNair K Patel S Urban L James I The role of central and peripheral Cannabinoid(1) receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain Pain 2001, 92(1-2):91-100. 10.1016/S0304-3959(00)00474-7 11323130
10. Malan TP Ibrahim MM Deng HF Liu Q Mata HP Vanderah T Porreca F Makriyannis A CB2 cannabinoid receptor-mediated peripheral antinociception Pain 2001, 93(3):239-245. 10.1016/S0304-3959(01)00321-9 11514083
11. Scott DA Wright CE Angus JA Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat Pain 2004, 109(1-2):124-131. 10.1016/j.pain.2004.01.020 15082134
12. Burstein SH The cannabinoid acids: Nonpsychoactive derivatives with therapeutic potential Pharmacol Ther 1999, 82(1):87-96. 10.1016/ S0163-7258(98)00069-2 10341359
13. Huang SM Bisogno T Petros TJ Chang SY Zavitsanos PA Zipkin RE Sivakumar R Coop A Maeda DY De Petrocellis L Burstein S Di Marzo V Walker JM Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain J Biol Chem 2001, 276(46):42639-42644. 10.1074/jbc.M107351200 11518719
14. Sheskin T Hanus L Slager J Vogel Z Mechoulam R Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor J Med Chem 1997, 40(5):659-667. 10.1021/jm960752x 9057852
15. Burstein SH Adams JK Bradshaw HB Fraioli C Rossetti RG Salmonsen RA Shaw JW Walker JM Zipkin RE Zurier RB Potential anti-inflammatory actions of the elmiric (lipoamino) acids Bioorganic & Medicinal Chemistry 2007, 15(10):3345-3355. 1896102 17383881 10.1016/j.bmc.2007.03.026
16. Vuong LAQ Mitchell VA Vaughan CW Actions of N-arachidonyl-glycine in a rat neuropathic pain model Neuropharmacology 2007 (in press).
17. Van Sickle MD Duncan M Kingsley PJ Mouihate A Urbani P Mackie K Stella N Makriyannis A Piomelli D Davison JS Marnett LJ Di Marzo V Pittman QJ Patel KD Sharkey KA Identification and functional characterization of brainstem cannabinoid CB2 receptors Science 2005, 310(5746):329-332. 10.1126/science.1115740 16224028
18. Beltramo M Bernardini N Bertorelli R Campanella M Nicolussi E Fredduzzi S Reggiani A CB2 receptor-mediated antihyperalgesia: Possible direct involvement of neural mechanisms Eur J Neurosci 2006, 23(6):1530-1538. 10.1111/j.1460-9568.2006.04684.x 16553616
19. Zhang J Hoffert C Vu HK Groblewski T Ahmad S O'Donnell D Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models Eur J Neurosci 2003, 17(12):2750-2754. 10.1046/j.1460-9568.2003.02704.x 12823482
20. Nackley AG Makriyannis A Hohmann AG Selective activation of cannabinoid CB2 receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation Neuroscience 2003, 119(3):747-757. 10.1016/S0306-4522(03)00126-X 12809695
21. Elmes SJR Winyard LA Medhurst SJ Clayton NM Wilson AW Kendall DA Chapman V Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat Pain 2005, 118(3):327-335. 10.1016/j.pain.2005.09.005 16289798
22. Wotherspoon G Fox A McIntyre P Colley S Bevan S Winter J Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons Neuroscience 2005, 135(1):235-245. 10.1016/ j.neuroscience.2005.06.009 16084654
23. Sagar DR Kelly S Millns PJ O'Shaughnessey CT Kendall DA Chapman V Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats Eur J Neurosci 2005, 22(2):371-379. 10.1111/j.1460-9568.2005.04206.x 16045490
24. Burstein SH Huang SM Petros TJ Rossetti RG Walker JM Zurier RB Regulation of anandamide tissue levels by N-arachidonylglycine Biochem Pharm 2002, 64(7):1147-1150. 10.1016/S0006-2952(02)01301-1 12234618
25. Prusakiewicz JJ Kingsley PJ Kozak KR Marnett LJ Selective oxygenation of N-arachidonylglycine by cyclooxygenase-2 Biochem Biophys Res Commun 2002, 296(3):612-617. 10.1016/S0006-291X(02)00915-4 12176025
26. Kohno M Hasegawa H Inoue A Muraoka M Miyazaki T Oka K Yasukawa M Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18 Biochem Biophys Res Commun 2006, 347(3):827-832. 10.1016/j.bbrc.2006.06.175 16844083
27. Wiles AL Pearlman RJ Rosvall M Aubrey KR Vandenberg RJ N-Arachidonyl-glycine inhibits the glycine transporter, GLYT2a J Neurochem 2006, 99(3):781-786. 10.1111/j.1471-4159.2006.04107.x 16899062
28. Yaksh TL Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: Effects of modulatory receptor systems and excitatory amino acid antagonists Pain 1989, 37(1):111-123. 10.1016/0304-3959(89)90160-7 2542867
29. Sherman SE Luo L Dostrovsky JO Spinal strychnine alters response properties of nociceptive-specific neurons in rat medial thalamus J Neurophysiol 1997, 78(2):628-637. 9307100
30. Cronin JN Bradbury EJ Lidierth M Laminar distribution of GABAA- and glycine-receptor mediated tonic inhibition in the dorsal horn of the rat lumbar spinal cord: Effects of picrotoxin and strychnine on expression of Fos-like immunoreactivity Pain 2004, 112(1-2):156-163. 10.1016/ j.pain.2004.08.010 15494196
31. Di Marzo V De Petrocellis L Bisogno T The biosynthesis, fate and pharmacological properties of endocannabinoids Handbook of Experimental Pharmacology: Cannabinoids Berlin, Springer Pertwee RG 2005, 168:147-185.
32. Chaplan SR Bach FW Pogrel JW Chung JM Yaksh TL Quantitative asessment of tactile allodynia in the rat paw J Neurosci Methods 1994, 53:55-63. 10.1016/0165-0270(94)90144-9 7990513
33. Hargreaves K Dubner R Brown F Flores C Joris J A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia Pain 1988, 32(1):77-88. 10.1016/0304-3959(88)90026-7 3340425